Fulgent Genetics, Inc. ã¯ãåäŒç€Ÿãšãšãã«ãèšåºçã«å®è¡å¯èœãªèšºææ
å ±ãæã€å»åž«ã« COVID-19 æ€æ»ããã³éºäŒåæ€æ»ãµãŒãã¹ãæäŸããŠããŸããå瀟ã®ãã¯ãããžãŒ ãã©ãããã©ãŒã ã¯ãããŒã¿æ¯èŒããã³æå¶ã¢ã«ãŽãªãºã ãé©å¿åŠç¿ãœãããŠã§ã¢ãéºäŒå蚺æããŒã«ãçµ±åã©ã ããã»ã¹ãçµ±åããŠããŸããå瀟ã¯äž»ã«ä¿éºäŒç€Ÿãç
é¢ãå»çæ©é¢ã«ãµãŒãã¹ãæäŸããŠããŸããå瀟ã¯ã瀟å
å¶æ¥æ
åœè
ãéããŠããŸãç±³åœããã³æµ·å€ã®ç¬ç«å¶æ¥æ
åœè
ãéããŠæ€æ»ã販売ããŠããŸããFulgent Genetics ã¯ãPWNHealth ãšååããŠåšå®
COVID-19 æ€æ»æ©èœãæäŸããŠãããHelio Health, Inc. ãšæŠç¥çããŒãããŒã·ãããçµãã§è¡æ¶²ããŒã¹ã®æ©æããæ€åºæ€æ»ãåååããŠããŸããå瀟ã¯ä»¥å㯠Fulgent Diagnostics, Inc. ãšããŠç¥ãããŠããŸãããã2016 幎 8 æã« Fulgent Genetics, Inc. ã«ç€Ÿåã倿ŽããŸãããFulgent Genetics, Inc. 㯠2011 幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ãã³ãã« ã·ãã£ã«æ¬ç€Ÿã眮ããŠããŸãã